David M. Weinstock

19.8k citations

169 papers · 6.8k indexed · h-index 46

Impact in

Oncology top 1%
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
Cancer Research top 2%

Papers in

Genetics 31
- Chronic Lymphocytic Leukemia Research 27
Hematology 30
- Chronic Myeloid Leukemia Treatments 18

Co-authors: Maria Jasin Arthur E. Brown Erika Brunet Oliver Weigert C. Norman Coleman Beth Elliott Dipanjan Chowdhury Judith L. Bader
Journals: Blood (62 papers)Blood Advances (5 papers)Proceedings of the National Academy of Sciences (4 papers)British Journal of Haematology (3 papers)Cancer Research (3 papers)
Partner nations: United States Germany Canada

In The Last Decade

David M. Weinstock

164 papers receiving 6.7k citations

Peers

Countries citing papers authored by David M. Weinstock

Since Specialization

Citations

This map shows the geographic impact of David M. Weinstock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Weinstock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Weinstock more than expected).

Fields of papers citing papers by David M. Weinstock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Weinstock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Weinstock. The network helps show where David M. Weinstock may publish in the future.

Co-authors

The 25 scholars most cited alongside David M. Weinstock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Weinstock Line = papers co-authored together David M. Weinstock links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma Leukemia ·Marcos Sobral, Felix Korell, Irene Scarfò, M. Raunio, Karina Harumi Inaka, Maria de Los Angeles Gasalla, Inês Mourato, Robert L.Maddex, Danilo Christiaan, Cort Stewart Thoreson, Harrison Silva, Gongwei Wu, Anthony Letai, Kimberly Stegmaier, Jens G. Lohr, David M. Weinstock, Marcela V. Maus, Birgit Knoechel	2025	1
2	Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia Blood Cancer Journal ·孙光林, James Dongjoo Ham, Xiaopei Liu, Lan Nguyễn, Toni Delorey, Azucena Ramos, David M. Weinstock, Aviv Regev, Michael T. Hemann	2023	1
3	Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1 Molecular Cancer Therapeutics ·Adrian Schwarzer, Matheus Oliveira, ชวลิต วายุภักตร์, Kanta Chakraborty, Sidiq Arsyadi, Brad Koch, Mark Hannink, Axel Schambach, Henny Lucyda, Kristi Asser, Matthias Gaestel, Todd Hembrough, FaiAli Alotaibi, Michael Luther, Michael Stocum, Linsey Stiles, David M. Weinstock, Marc Liesa, Matthew J. Kostura	2023	6
4	(Re)Minding the obvious Hematological Oncology ·David M. Weinstock	2023	1
5	RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia Oncogene ·Injamam ul Haque, 寺本恵介, Zhenhua Li, Emanuela Giarin, Jürgen Groet, SF Bodjrenou, Shirley Kow‐Yin Kham, Wee Joo Chng, Hany Ariffin, David M. Weinstock, Allen Eng Juh Yeoh, Giuseppe Basso, Dean Nižetić	2020	8
6	Parp3 promotes long-range end joining in murine cells Proceedings of the National Academy of Sciences ·Jacob V. Layer, John P. Cleary, Alexander J. Brown, Kristen E. Stevenson, Sara Morrow, Alexandria Van Scoyk, Rafael B. Blasco, Elif Karaca, Fei‐Long Meng, Richard L. Frock, Trevor Tivey, Sunhee S. Kim, Chaiyong Chuchart, Roberto Chiarle, Frederick W. Alt, Steven A. Roberts, David M. Weinstock, Tovah A. Day	2018	12
7	Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas Blood ·Irene Scarfò, Maria Ormhøj, Matthew J. Frigault, Ana P. Castaño, Selena Lorrey, Amanda A. Bouffard, Alexandria Van Scoyk, Scott J. Rodig, Cristian Juberthie, Jon C. Aster, Frederic I. Preffer, David M. Weinstock, Marcela V. Maus	2018	105
8	B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies Cell ·Gang Xiao, Lai N. Chan, Lars Klemm, Daniel Braas, Zhengshan Chen, Huimin Geng, Fabio Barreto Schuch, Ali Aghajanirefah, Kadriye Nehir Cosgun, Teresa Sadras, Jae Woong Lee, Tamara Mirzapoiazova, Ravi Salgia, Thomas Ernst, Andreas Hochhaus, Hassan Jumaa, Xiaoyan Jiang, David M. Weinstock, Thomas G. Graeber, Markus Müschen	2018	91
9	Dynamic BH3 Profiling Reveals Novel Therapeutic Strategies for the Treatment of Double-Hit Lymphoma Blood ·Jennifer L. Crombie, Laura Kristine Hickman, Kristopher A. Sarosiek, Amanda L. Christie, Cameron Fraser, Shruti Bhatt, Jing Deng, Matthew S. Davids, David M. Weinstock, Anthony Letai	2017	2
10	Circulating Micrornas (miRNA) As a Novel Liquid Biopsy and Therapeutic Platform in MYC and Non-MYC Diffuse Large B-Cell Lymphoma (DLBCL) Blood ·Afshin Beheshti, Charles Vanderburg, Dashnamoorthy Ravi, J. Tyson McDonald, Amanda L. Christie, Susan Aitkin, Frederic Conneit White, Hong Zhang, David M. Weinstock, Andrew M. Evens	2017	1
11	Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma Blood ·Steven M. Horwitz, Raphael Koch, Pierluigi Porcu, Yasuhiro Oki, Alison J. Moskowitz, Megan N. Perez, Patricia L. Myskowski, Adam Officer, Jacob D. Jaffe, Sara Morrow, Kerstin Allen, Mark Douglas, Howard M. Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Jon C. Aster, David T. Weaver, Francine M. Foss, David M. Weinstock	2017	204
12	Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia Clinical Cancer Research ·Yana Pikman, Gabriela Alexe, Giovanni Roti, Amy Saur Conway, Tamyres Furtado da Hora, Patricia Lem, Andrew E. Place, Sunkyu Kim, Chitra Saran, Mohsen Raeesi, David M. Weinstock, Marian H. Harris, Andrew L. Kung, Lewis B. Silverman, Kimberly Stegmaier	2016	81
13	Public Health and Medical Preparedness for a Nuclear Detonation Health Physics ·C. Norman Coleman, Julie M. Sullivan, Judith L. Bader, An Ngoc Nguyen, John F. Koerner, Valeria Rosas BA, David M. Weinstock, د.عزالدين الصغير, Chad Hrdina, Э А Кашуба, Ion Ioniţă, Ellie Graeden, A. Ferriz-Valero, Timothy Lant, Bert W. Maidment, Alisson Akerman	2014	31
14	BCL2 Suppresses PARP1 Function and Nonapoptotic Cell Death Cancer Research ·Chaitali Dutta, Tovah A. Day, Nadja Kopp, Diederik van Bodegom, Matthew S. Davids, Jeremy Ryan, Liat Bird, Naveen Kommajosyula, Oliver Weigert, Akinori Yoda, Hua Fung, Jennifer R. Brown, Geoffrey I. Shapiro, Anthony Letai, David M. Weinstock	2012	45
15	Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation Cancer Discovery ·Oliver Weigert, Nadja Kopp, Andrew A. Lane, Akinori Yoda, Suzanne E. Dahlberg, Donna Neuberg, Anita Y. Bahar, Bjoern Chapuy, Jeffery L. Kutok, Janina A. Longtine, Frank C. Kuo, Terry Haley, G M Blok, Timothy J. Sullivan, David C. Fisher, Edward A. Fox, Scott J. Rodig, Joseph H. Antin, David M. Weinstock	2011	64
16	Health Care System Planning for and Response to a Nuclear Detonation Disaster Medicine and Public Health Preparedness ·John L. Hick, David M. Weinstock, C. Norman Coleman, Dan Hanfling, Stephen V. Cantrill, Irwin Redlener, Judith L. Bader, An Ngoc Nguyen, Ann R. Knebel	2011	38
17	New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients Expert Opinion on Pharmacotherapy ·Gianvincenzo Zuccotti, Lynne Strasfeld, David M. Weinstock	2005	9
18	Rhodococcus equi:An Emerging Pathogen Clinical Infectious Diseases ·David M. Weinstock, Arthur E. Brown	2002	199
19	Rotavirus outbreak on a pediatric oncology floor: Possible association with toys American Journal of Infection Control ·Irfany Muthia Rahmah, David M. Weinstock, Janet Eagan, Timothy E. Kiehn, Donald Armstrong, Kent A. Sepkowitz	2000	37
20	Metastatic Testicular Embryonal Carcinoma in a Horse Veterinary Pathology ·Beth A. Valentine, David M. Weinstock	1986	12

About David M. Weinstock

David M. Weinstock is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Emergency Medical Services, having authored 169 papers that have together received 6.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (27 papers), CAR-T cell therapy research (25 papers), DNA Repair Mechanisms (23 papers), Chronic Myeloid Leukemia Treatments (18 papers), Acute Lymphoblastic Leukemia research (18 papers), Protein Degradation and Inhibitors (14 papers) and Disaster Response and Management (13 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (960 citations), Hematology (703 citations), Genetics (635 citations) and Pathology and Forensic Medicine (1.1k citations). David M. Weinstock has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Maria Jasin, Arthur E. Brown, Erika Brunet, Oliver Weigert, C. Norman Coleman, Beth Elliott, Dipanjan Chowdhury, Judith L. Bader, Nadja Kopp and Patryk Moskwa. Their work appears in journals such as Blood, Blood Advances, Proceedings of the National Academy of Sciences, British Journal of Haematology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact